Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children

Abstract Objective: To describe and analyze the occurrence of hospitalizations for community-acquired pneumonia in children before and after the pneumococcal 10-valent conjugate vaccine implementation into the National Immunization Program. Methods: This is an ecological study that includes record...

Full description

Bibliographic Details
Main Authors: Sandra Rodrigues da Silva, Luane Marques de Mello, Anderson Soares da Silva, Altacílio Aparecido Nunes
Format: Article
Language:English
Published: Sociedade de Pediatria de São Paulo
Series:Revista Paulista de Pediatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822016000400418&lng=en&tlng=en
_version_ 1811329744796385280
author Sandra Rodrigues da Silva
Luane Marques de Mello
Anderson Soares da Silva
Altacílio Aparecido Nunes
author_facet Sandra Rodrigues da Silva
Luane Marques de Mello
Anderson Soares da Silva
Altacílio Aparecido Nunes
author_sort Sandra Rodrigues da Silva
collection DOAJ
description Abstract Objective: To describe and analyze the occurrence of hospitalizations for community-acquired pneumonia in children before and after the pneumococcal 10-valent conjugate vaccine implementation into the National Immunization Program. Methods: This is an ecological study that includes records of children younger than one year old, vaccinated and not vaccinated with the pneumococcal 10-valent conjugate vaccine in the periods pre- and post-inclusion of the vaccine in the National Immunization Program in the area covered by the Regional Health Superintendence of Alfenas, state of Minas Gerais, Brazil. Vaccination was considered as the exposure factor and hospitalization for community-acquired pneumonia as the endpoint, using secondary annual data by municipality. The prevalence ratio and its 95% confidence interval (95%CI) were used to verify the association between variables. The Z test was used to calculate the difference between proportions. Results: Considering the 26 municipalities of the Regional Health Superintendence of Alfenas, there was a significant reduction in hospitalizations for community-acquired pneumonia in children younger than one year of age, with prevalence ratio (PR)=0.81 (95%CI: 0.74-0.89; p<0.05), indicating a 19% lower prevalence of hospitalization for community-acquired pneumonia in the post-vaccination period. Conclusions: The results suggest the effectiveness of the pneumococcal 10-valent conjugate vaccine in preventing severe cases of community-acquired pneumonia in children younger than one year of age.
first_indexed 2024-04-13T15:49:19Z
format Article
id doaj.art-fd1e3e745aee4313a0f13b14aec12465
institution Directory Open Access Journal
issn 1984-0462
language English
last_indexed 2024-04-13T15:49:19Z
publisher Sociedade de Pediatria de São Paulo
record_format Article
series Revista Paulista de Pediatria
spelling doaj.art-fd1e3e745aee4313a0f13b14aec124652022-12-22T02:40:54ZengSociedade de Pediatria de São PauloRevista Paulista de Pediatria1984-046234441842410.1016/j.rppede.2016.03.008S0103-05822016000400418Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in childrenSandra Rodrigues da SilvaLuane Marques de MelloAnderson Soares da SilvaAltacílio Aparecido NunesAbstract Objective: To describe and analyze the occurrence of hospitalizations for community-acquired pneumonia in children before and after the pneumococcal 10-valent conjugate vaccine implementation into the National Immunization Program. Methods: This is an ecological study that includes records of children younger than one year old, vaccinated and not vaccinated with the pneumococcal 10-valent conjugate vaccine in the periods pre- and post-inclusion of the vaccine in the National Immunization Program in the area covered by the Regional Health Superintendence of Alfenas, state of Minas Gerais, Brazil. Vaccination was considered as the exposure factor and hospitalization for community-acquired pneumonia as the endpoint, using secondary annual data by municipality. The prevalence ratio and its 95% confidence interval (95%CI) were used to verify the association between variables. The Z test was used to calculate the difference between proportions. Results: Considering the 26 municipalities of the Regional Health Superintendence of Alfenas, there was a significant reduction in hospitalizations for community-acquired pneumonia in children younger than one year of age, with prevalence ratio (PR)=0.81 (95%CI: 0.74-0.89; p<0.05), indicating a 19% lower prevalence of hospitalization for community-acquired pneumonia in the post-vaccination period. Conclusions: The results suggest the effectiveness of the pneumococcal 10-valent conjugate vaccine in preventing severe cases of community-acquired pneumonia in children younger than one year of age.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822016000400418&lng=en&tlng=enPneumoniaStreptococcus pneumoniaeImunizaçãoVacina pneumocócicaHospitalizaçãoCriança
spellingShingle Sandra Rodrigues da Silva
Luane Marques de Mello
Anderson Soares da Silva
Altacílio Aparecido Nunes
Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
Revista Paulista de Pediatria
Pneumonia
Streptococcus pneumoniae
Imunização
Vacina pneumocócica
Hospitalização
Criança
title Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
title_full Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
title_fullStr Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
title_full_unstemmed Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
title_short Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
title_sort impact of the pneumococcal 10 valent vaccine on reducing hospitalization for community acquired pneumonia in children
topic Pneumonia
Streptococcus pneumoniae
Imunização
Vacina pneumocócica
Hospitalização
Criança
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822016000400418&lng=en&tlng=en
work_keys_str_mv AT sandrarodriguesdasilva impactofthepneumococcal10valentvaccineonreducinghospitalizationforcommunityacquiredpneumoniainchildren
AT luanemarquesdemello impactofthepneumococcal10valentvaccineonreducinghospitalizationforcommunityacquiredpneumoniainchildren
AT andersonsoaresdasilva impactofthepneumococcal10valentvaccineonreducinghospitalizationforcommunityacquiredpneumoniainchildren
AT altacilioaparecidonunes impactofthepneumococcal10valentvaccineonreducinghospitalizationforcommunityacquiredpneumoniainchildren